FDA issued a Warning Letter to CP Pharmaceuticals on 11/16/2016 as a result of this inspection.
483 CP Pharmaceuticals Oct 2015

483 CP Pharmaceuticals Oct 2015

Torrance Slayton FDA$119.00 - Available Now

FDA investigators audited the CP Pharmaceuticals - Wrexham, United Kingdom facility and issued 13 inspectional observations (via FDA 483) on 13 Oct 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 13
  • Inspection end: 13 Oct 2015
  • Location: Wrexham, United Kingdom
  • FEI: 3003369660
Add To Cart